Loading clinical trials...

Medical Abortion Self-Confirmation (MASC) | Clinical Trials | Clareo Health

COMPLETEDNA

Medical Abortion Self-Confirmation (MASC)

Medication Abortion Self-Confirmation (MASC): Comparison of Two Home Pregnancy Tests as an Alternative to Office Follow-up

NCT03148587•Stanford University

View on ClinicalTrials.gov

Summary

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, without routine provider contact.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Gestational age of less than or equal to 63 days
•English speaking
•Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
•In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form

Exclusion Criteria

•Allergy to mifepristone and/or misoprostol
•Non-english speaking
•Inability to access internet

Locations (1)

Stanford Health Care

Stanford, California, United States

Key Dates

Start Date

May 1, 2017

Primary Completion Date

May 31, 2018

Completion Date

May 31, 2018

Last Updated

June 7, 2019

Enrollment

ACTUAL participants

Conditions

Medical Abortion

Interventions

Self-assessment: MLPT

BEHAVIORAL

Self-assessment: LSPT

BEHAVIORAL

Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :

NCT06708208

PregnancyViolence Against Women (VAW)+5 more

View study

NOT_YET_RECRUITING

Long Term Impact of Induced Abortion

NCT06795334

Non-medical Abortion Surgery

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 7, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Medical Abortion Self-Confirmation (MASC)

Inclusion Criteria

Exclusion Criteria

Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :

Long Term Impact of Induced Abortion

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Methadone and Medication Abortion

Cannabinoids for Pain Control During Medical Abortion

Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy